MRGN Advisors was established in 2015 to advise CEOs, supervisory boards and investors on portfolio strategy, commercial and market access development, partnering and investment advisory in pharma, biologicals, vaccines, med tech and healthcare IT.
Even monkeys fall from trees — Japanese Proverb
Pierre Morgon
CEO & Founder
Plus Group
Finance and Accounting
Thierry Weber
Philippe Meuwly
Jehan Cellier
Agnès Oertli
Pierre Morgon
Nicolas Ristic
Paul Kirkconnell
Sam Liao
Pierre Morgon
Alain Rinaldi
MRGN Advisors is involved in healthcare infrastructure projects in Switzerland, such as the set-up of specialized surgical centers and clinics.
MRGN designs innovative solutions customized to clients’ needs, aiming at maximizing the value of product development, market access, manufacturing footprint, launch and life cycle management.
MRGN Advisors provides an exclusive competitive edge in the pharmaceutical sector by leveraging firsthand experience of the environment, anticipate trends and translate them into opportunities for our clients in the fields of Oncology, Cardiovascular, Central Nervous System, Dermatology and Allergology.
MRGN Advisors capitalizes on direct operational experience in healthcare investment and operations management to deliver innovation, business development and partnering, funding and access strategies.
MRGN advisors brings decades of expertise in both multinational and start-up vaccine companies, and a worldwide network of experts spanning the entire value chain of vaccines, delivering cutting-edge solutions for research, development, manufacturing, regulatory, market access and immunization policy strategies.
MRGN Advisors capitalizes on a unique understanding of the med tech sector in Switzerland to provide insights to investors and companies in designing innovation, partnering, financing and market access strategies.
MRGN Advisors is providing insights to investors and healthcare companies looking for opportunities in the fast evolving, vibrant and sometimes confusing sector of healthcare IT.